# US 2026/0102326 A1 · Sunscreen composition with low stickiness

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0102326 A1
- Document ID: US20260102326A1
- Status: Published application
- Kind: A1
- Application number: 19/420,538
- Filed: 2025-12-15
- Published: 2026-04-16
- Earliest claimed: 2019-11-05
- Assignees: Dsm IP Assets B.V.
- Applicants: DSM IP Assets B.V.
- Inventors: Anne JANSSEN; Karina Radomsky; Thomas Rudolph
- Web page: https://patentgrep.com/patent/US20260102326A1

## CPC

- A61K 8/585: {Organosilicon compounds}
- A61Q 17/00: Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61K 8/062: {Oil-in-water emulsions}
- A61K 8/27: Zinc; Compounds thereof
- A61K 8/34: Alcohols
- A61K 8/4946: {Imidazoles or their condensed derivatives, e.g. benzimidazoles}
- A61K 8/4966: {Triazines or their condensed derivatives}
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61K 2800/30: Characterized by the absence of a particular group of ingredients
- A61K 2800/413: Nanosized, i.e. having sizes below 100 nm
- A61K 2800/623: Coating mediated by organosilicone compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The embodiments of present invention disclosed herein relate to a topical preparation comprising a UV filter combination of certain microfine zinc oxide, 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: Bis-Ethylhexyloxyphenol methoxyphenyl Triazine), 2-phenylbenzimidazole-5-sulfonic acid and/or one or more salts thereof and 2,4,6-tris[anilino(p-carbo-2′-ethyl-1′-hexyloxy)]-1,3,5-triazine (INCI: Ethylhexyl Triazone).

## Claims

### Claim 1

A topical composition, wherein the composition comprises a UV filter combination comprised of:
(a) a microfine zinc oxide, wherein the microfine zinc oxide has a mean particle size Dn50 as determined by Laser diffraction selected in the range from 30 to 200 nm and a surface coating selected from the group consisting of triethoxycaprylylsilane, octyltrimethoxysilane and dimethicone,
(b) 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: Bis-Ethylhexyloxyphenol methoxyphenyl Triazine),
(c) 2-phenylbenzimidazole-5-sulfonic acid and/or one or more salts thereof, and
(d) 2,4,6-tris[anilino(p-carbo-2′-ethyl-1′-hexyloxy)]-1,3,5-triazine (INCI: Ethylhexyl Triazone).

### Claim 2 (depends on 1)

The topical composition according to claim 1, wherein the microfine zinc oxide has a mean particle size selected of 50 to 200 nm as determined by Laser diffraction.

### Claim 3 (depends on 1)

The topical composition according to claim 1, wherein the microfine zinc oxide is surface coated with triethoxycaprylylsilane.

### Claim 4 (depends on 1)

The topical composition according to claim 1, wherein the amount of the microfine zinc oxide is selected in the range from 0.1 wt.-% to 20 wt.-%, based on the total weight of the composition.

### Claim 5 (depends on 1)

The topical composition according to claim 1, wherein the composition contains no 3-(4-methylbenzylidene) camphor, 2-hydroxy-4-methoxybenzophenone (INCI: Oxybenzone), and ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: Octocrylene).

### Claim 6 (depends on 1)

The topical composition according to claim 1, wherein the composition is an O/W emulsion.

### Claim 7 (depends on 1)

The topical composition according to claim 1, wherein the composition is a W/O emulsion.

### Claim 8 (depends on 1)

The topical composition according to claim 1, wherein the composition further comprises at least one emulsifier selected from the group consisting of Ceteareth-6 and Ceteareth-25.

### Claim 9 (depends on 1)

The topical composition according to claim 1, wherein the composition further comprises one or more of dibutyl adipate, dicaprylyl carbonate and/or C12-C15 alkylbenzoate.

### Claim 10 (depends on 1)

The topical composition according to claim 1, wherein the composition comprises one or more of ethanol, p-hydroxyacetophenone, phenoxyethanol and/or ethylhexylglycerin.

### Claim 11 (depends on 1)

The topical composition according to claim 1, wherein the composition comprises one or more of xanthan gum, crosslinked acrylate/C10-C30 alkyl acrylate polymer, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer & Squalane & Polysorbate 60 and/or vinylpyrrolidone/hexadecene copolymer.

### Claim 12 (depends on 1)

The topical composition according to claim 1, wherein the composition comprises one or more of cetyl alcohol, cetearyl alcohol, stearyl alcohol and/or glyceryl stearate.

### Claim 13 (depends on 1)

The topical composition according to claim 1, wherein the composition has an SPF of at least 20.

### Claim 14 (depends on 1)

The topical composition according to claim 1, wherein the microfine zinc oxide has a mean particle size of 75 to 150 nm as determined by Laser diffraction.

### Claim 15 (depends on 1)

The composition according to claim 1, wherein the microfine zinc oxide has a mean particle size of 90 to 130 nm as determined by Laser diffraction.

### Claim 16 (depends on 1)

The topical composition according to claim 1, wherein the amount of the microfine zinc oxide is 0.5 wt.-% to 10 wt.-%, based on the total weight of the composition.

### Claim 17 (depends on 1)

The topical composition according to claim 1, wherein the amount of the microfine zinc oxide is 5 wt.-% to 10 wt.-%, based on the total weight of the composition.

### Claim 18 (depends on 1)

The topical composition according to claim 1, wherein the microfine zinc oxide component (a) is present in an amount sufficient to reduce stickiness of the topical composition when applied to skin as determined by reduced sand adherence on the skin as compared to an identical topical composition that does not contain the microfine zinc oxide.

### Claim 19

A method for reducing the stickiness and/or the sand adherence on skin of a topical composition, the method comprising:
(a) providing a topical composition comprising (i) 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: Bis-Ethylhexyloxyphenol methoxyphenyl Triazine), (ii) 2-phenylbenzimidazole-5-sulfonic acid and/or one or more salts thereof, and (iii) at least one of 2,4,6-tris[anilino(p-carbo-2′-ethyl-1′-hexyloxy)]-1,3,5-triazine (INCI: Ethylhexyl Triazone), and
(b) incorporating into the topical composition of step (a) before application of the topical composition to skin an amount of microfine zinc oxide having a mean particle size Dn50 as determined by Laser diffraction selected in the range from 30 to 200 nm and a surface coating selected of triethoxycaprylylsilane sufficient to reduce the stickiness and/or the sand adherence on skin of the topical composition.
